05/11 | Australia shares slide as U.S. inflation data fuels slowdown woes | RE |
05/11 | Australian shares rise on healthcare, mining boost; U.S. inflation data in focus | RE |
05/06 | Australia shares slump as inflation woes hint at more rate hikes | RE |
04/20 | CSL Prices $4 Billion of Bonds in US Debt Market | MT |
04/20 | PAUL RAMSAY : KKR-led group offers record $14.8 billion bid for Australia's Ramsay Health | RE |
03/31 | Australia shares inch lower on tech, energy losses | RE |
03/29 | CSL Behring - European Medicines Agency Commences Review of Novel Gene Therapy Candidat.. | AQ |
03/28 | Seqirus Receives Health Canada Approval for Expanded Age Indication of Its Cell-Based Q.. | AQ |
03/23 | CSL BEHRING AG - PUBLICATION OF PROV : Participation rate of 94 percent | AQ |
03/17 | Australian shares boosted by energy, mining stocks; set for best week in 13 months | RE |
03/15 | Australian shares rise on banks, tech boost; Fed meeting in focus | RE |
03/13 | Australian shares jump 1% on banking, energy boost | RE |
03/08 | PUBLICATION OF DEFINITIVE INTERIM RE : CSL Behring AG declares offer successful | BU |
03/07 | Australian shares see-saw amid global sell-off, NZ in correction territory | RE |
03/07 | Seqirus - Update on CDC Advisory Committee on Immunization Practices (ACIP) Review of E.. | AQ |
03/07 | CSL LIMITED : Ex-dividend day for interim dividend | FA |
03/06 | CSL : Notification regarding unquoted securities - CSL | PU |
03/03 | CSL : Notification regarding unquoted securities - CSL | PU |
03/03 | Vifor Pharma Group - Publication of provisional interim result for Vifor Pharma tender .. | AQ |
03/03 | Forbes Magazine Ranks Global Biotech Leader CSL Among America's Best Employers for 2022 | AQ |
02/27 | Australian shares inch lower on Ukraine concerns | RE |
02/24 | S.Africa building giant WBHO quits Australia, blames 'hardline' COVID response | RE |
02/23 | S.Africa building giant WBHO quits Australia, blames 'hardline' COVID response | RE |
02/23 | CSL : Change of Director's Interest Notice | PU |
02/23 | CSL : Notification regarding unquoted securities - CSL | PU |
02/23 | S.Africa building giant WBHO quits Australia, blames 'hardline' COVID response | RE |
02/23 | Australia shares end higher with Russia-Ukraine standoff in focus | RE |
02/16 | GLOBAL MARKETS LIVE : AirBnb, Heineken, Hilton, SeaWorld, Airbus... | |
02/16 | CSL Posts Lower Fiscal H1 Profit as Expenses Rise | MT |
02/16 | Australian Shares Rebound on Boost from Healthcare Rally | MT |
02/15 | Australia biotech firm CSL says plasma business hit by Omicron, but demand robust | RE |
02/15 | Australia shares rise as Russia-Ukraine tensions ease | RE |
02/15 | TRANSCRIPT : CSL Limited, H1 2022 Earnings Call, Feb 16, 2022 | CI |
02/15 | CSL 1st Half Net Profit Falls as Immunoglobulin Sales Decline | DJ |
02/15 | CSL : Half Year Results Investor Presentation | PU |
02/15 | CSL : Half Year Results Announcement | PU |
02/15 | CSL : Statutory Accounts for Half Year Ended 31 December 2021 | PU |
02/15 | CSL Limited Reports Earnings Results for the Half Year Ended December 31, 2021 | CI |
02/15 | CSL Limited Provides Earnings Guidance for the Fiscal Year 2022 | CI |
02/15 | CSL Limited Announces Ordinary Cash Dividend for the Six Months Ended December 31, 2021.. | CI |
02/13 | CSL Completes $534 Million Share Purchase Plan | MT |
02/13 | CSL : Application for quotation of securities - CSL | PU |
02/07 | CSL Behring - Final Analysis of Pivotal HOPE-B Study Demonstrates Durable and Sustained.. | AQ |
02/07 | Australian shares weighed down by banking, healthcare stocks | RE |
02/07 | Australian shares weighed down by banking, healthcare stocks | RE |
02/06 | Banks weigh on Australia shares as ANZ outlook disappoints | RE |
01/06 | CSL : Notification regarding unquoted securities - CSL | PU |
01/04 | Australian shares fall from 5-month high as tech losses weigh | RE |
2021 | Australian shares flat as banks negate gains in mining, tech stocks | RE |
2021 | Australian Shares Climb to Five-Day High on Boost from Healthcare Counter; Marley Spoon.. | MT |
2021 | Healthcare, mining stocks help Australian shares notch best day in 2 weeks | RE |
2021 | Global biotherapeutics - CSL Behring Receives Accelerated CHMP Assessment for Etranacog.. | AQ |
2021 | Australian Shares on Three-Day Fall; Debutant XPON Technologies Jump 20% | MT |
2021 | CSL, energy stocks drag Australia shares lower; tech rally limits losses | RE |
2021 | CSL Closes $4.5 Billion Share Placement; to Open Share Purchase Plan; Shares Sink 8% | MT |
2021 | CSL drags Australian shares lower, tech stocks rise | RE |
2021 | EUROPE : European shares fall again with cenbank meetings in focus | RE |
2021 | Global markets live: UBS, Toyota, MGM Resorts, Ocado, Nike... | |
2021 | EUROPEAN MIDDAY BRIEFING - Shares on Hold as -2- | DJ |
2021 | Vifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Billion | DJ |
2021 | TRANSCRIPT : CSL Limited, Vifor Pharma AG - M&A Call | CI |
2021 | CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update | DJ |
2021 | CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update | DJ |
2021 | Australia shares close flat as financials negate losses in retailers | RE |
2021 | CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma | DJ |
2021 | CSL : Investor Presentation CSL Swiss Tender Acquisition of Vifor | PU |
2021 | CSL : Swiss tender offer to acquire 100% of vifor pharma ltd | PU |
2021 | CSL : Proposed issue of securities - CSL | PU |
2021 | Australia's CSL to buy Swiss drugmaker Vifor for $11.7 bln | RE |
2021 | CSL : Committed to mRNA Program | PU |
2021 | Australia's CSL enters trading halt ahead of deal for drugmaker Vifor | RE |
2021 | GLOBAL MARKETS LIVE : General Motors, JP Morgan, Pfizer, Novavax, Ford... | |
2021 | EUROPEAN MIDDAY BRIEFING - Stocks Edge Higher, -2- | DJ |
2021 | Vifor Pharma and CSL Confirm Merger Talks | CI |
2021 | EMEA MORNING BRIEFING : Investors Eye Faster Fed -2- | DJ |